These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 14768436)

  • 1. Drug-eluting stents boost prices.
    Hosp Mater Manage; 2004 Jan; 29(1):1, 12-4. PubMed ID: 14768436
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug-eluting stent prices steady, usage declined over past several months.
    Hosp Mater Manage; 2007 Jun; 32(6):1, 5-8. PubMed ID: 17612009
    [No Abstract]   [Full Text] [Related]  

  • 3. How firms set prices for medical materials: a multi-country study.
    Ide H; Mollahaliloglu S
    Health Policy; 2009 Sep; 92(1):73-8. PubMed ID: 19342115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing the impact of drug-eluting stents. Hospitals must be prepared to absorb a potentially negative financial impact.
    Pfeiffer H
    Healthc Exec; 2003; 18(4):60-1. PubMed ID: 12841062
    [No Abstract]   [Full Text] [Related]  

  • 5. Can we afford to eliminate restenosis? Can we afford not to?
    Greenberg D; Bakhai A; Cohen DJ
    J Am Coll Cardiol; 2004 Feb; 43(4):513-8. PubMed ID: 14975456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Competition propping up. Second drug-eluting stent will be cheaper, plentiful.
    Becker C
    Mod Healthc; 2004 Mar; 34(11):12. PubMed ID: 15069793
    [No Abstract]   [Full Text] [Related]  

  • 7. [Is systematic use of drug-eluting stents justified? Arguments against].
    Macaya C
    Rev Esp Cardiol; 2004 Feb; 57(2):109-15. PubMed ID: 14967105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stent prices down, but not for long.
    Hosp Mater Manage; 2002 Nov; 27(11):1, 12-3. PubMed ID: 12442555
    [No Abstract]   [Full Text] [Related]  

  • 9. A proactive approach to reimbursement in the era of drug-eluting stents.
    Richner R
    J Cardiovasc Manag; 2002; 13(5):32-3. PubMed ID: 12412361
    [No Abstract]   [Full Text] [Related]  

  • 10. Hard to curb overuse of drug-eluting stents.
    Pope T
    Manag Care; 2006 Jun; 15(6):48, 51, 53. PubMed ID: 16838885
    [No Abstract]   [Full Text] [Related]  

  • 11. Welcome drop seen in stent prices.
    Hosp Mater Manage; 2006 Jul; 31(7):1, 5-6. PubMed ID: 16871664
    [No Abstract]   [Full Text] [Related]  

  • 12. [Potential impact of drug-eluting stents in Sicily: results from a multicenter survey and cost-benefit analysis of drug-eluting stents versus bare metal stents].
    Gulizia M; Martelli E; Tamburino C; Tolaro S; Frasheri A; Giambanco F; Grassi R; Fiscella A; Milazzo D
    Ital Heart J Suppl; 2004 Aug; 5(8):630-8. PubMed ID: 15554018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-eluting stents.
    Cohen DJ; Bakhai A
    CMAJ; 2007 May; 176(11):1612. PubMed ID: 17515592
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug-eluting stents.
    Rinfret S; Schampaert E
    CMAJ; 2007 May; 176(11):1611-2. PubMed ID: 17515589
    [No Abstract]   [Full Text] [Related]  

  • 15. Are drug-eluting stents cost-effective? It depends on whom you ask.
    Ryan J; Cohen DJ
    Circulation; 2006 Oct; 114(16):1736-43; discussion 1744. PubMed ID: 17043177
    [No Abstract]   [Full Text] [Related]  

  • 16. [Benefits and risks of drug-eluting stents].
    Zijlstra F
    Ned Tijdschr Geneeskd; 2007 May; 151(18):1005-7. PubMed ID: 17508683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paradigm shifts in cardiovascular medicine.
    Holmes DR; Firth BG; Wood DL
    J Am Coll Cardiol; 2004 Feb; 43(4):507-12. PubMed ID: 14975455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-eluting stents: a pharmacoclinical perspective.
    Thomas MK; Gupta YK
    Natl Med J India; 2006; 19(4):195-9. PubMed ID: 17100106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The paclitaxel-eluting stent in percutaneous coronary intervention: Part II. Comparison with the sirolimus-eluting stent, economics, and unanswered questions.
    Ray GM; Nawarskas JJ; Frishman WH
    Cardiol Rev; 2006; 14(3):143-50. PubMed ID: 16628023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Common sense, dollars and cents, and drug-eluting stents.
    Vaitkus PT
    J Am Coll Cardiol; 2006 Jul; 48(2):268-9. PubMed ID: 16843173
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.